Categories
- All
- Animal & Veterinary
- Award
- Biologics
- Coronavirus
- Cosmetics
- Design
- Dietary Supplements
- Drugs
- Follow @FDAmedia on Twitter
- Follow @FDAMedia on X
- Follow @US_FDA on Twitter
- Follow @US_FDA on X
- Follow FDA on Facebook
- Food & Beverages
- Healthy
- Hotel
- Infant Formula & Foods
- Infectious Disease
- Lifestyle
- Medical Devices
- Nature
- Office
- Over-the-Counter Drugs
- Tobacco
- Training
- Travel Tips
- Travel Tips
- Vaccines
Filter Articles
Search by title or filter by category
277 articles found
-
FDA Roundup: March 15, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA is announcing the availability of two draft guidance documents: “Human Ge... -
FDA Roundup: March 4, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published the FDA Voices: “CDER Continues to Make Rare Diseases a Priorit...
-
FDA Roundup: February 25, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Feb. 24, the FDA issued an update on our continuing efforts to understand and reduce...
-
FDA Roundup: February 22, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA posted a new resource, At-Home COVID-19 Diagnostic Tests, that provides a...
-
FDA Roundup: February 18, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA is announcing that it has found an additional four lots of AstraZeneca CO...
-
FDA Roundup: February 11, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Feb. 11, the U.S. Food and Drug Administration (FDA) opened the application portal fo...
-
Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron VariantToday, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID-19 that retains activity against the omicron variant....
-
Coronavirus (COVID-19) Update: FDA Postpones Advisory Committee Meeting to Discuss Request for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of AgeThe U.S. Food and Drug Administration has been notified by Pfizer that new data have recently emerged regarding its emergency use authorization request for the use of the Pfizer-BioNTech COVID-19 Vacc...
-
FDA Roundup: February 4, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Feb. 3, the FDA issued a revised draft guidance for industry, “Assessment of Pressor...
-
FDA Roundup: February 1, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Jan. 31, the FDA released a new video that provides an overview of the 2021 Food Alle...